hey @DocMcstuffins … if my memory serves me correctly you had some queries about CRP. In this video Dr Perin talks about IL-6 & CRP. All the prespecified secondary endpoints show great consistency. It’s all about the inflammation.
All this consistent data will make the next trial (confirmatory?) endpoints on point, particularly in targeting those patients with inflammation.
A great video on where to next.
CHF approval!
Cell Therapy News/Articles, page-13164
-
- There are more pages in this discussion • 4,657 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |